Study to Evaluate a Preop Dose of Brivoligide Injection for Pain After Knee Replacement in Patients With High PCS Scores
Status:
Withdrawn
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, Phase 2, randomized, double-blind, placebo-controlled study to
evaluate the safety and efficacy of brivoligide injection administered intrathecally before
surgery in patients with a Pain Catastrophizing Scale (PCS) score ≥16 undergoing primary
unilateral total knee arthroplasty.